Scant details are available but the joint venture between LTR Pharma and the Restorative Sexual Health Clinic will launch early in 2025.
LTR Pharma is launching into the telehealth market, announcing a joint venture with the Restorative Sexual Health Clinic to launch an online healthcare platform “dedicated to men’s health”.
The as-yet-unnamed platform will launch in the first quarter of 2025 and will offer treatments for erectile dysfunction and associated conditions like Peyronie’s disease, and premature ejaculation, according to a spokesperson for LTR Pharma.
“The platform will provide accessible, comprehensive health services, including medical consultations, therapeutic services, prescription treatments, and integrated health management solutions,” said the company announcement.
Services offered will include “professional medical consultations, comprehensive therapeutic services, prescription and non-prescription treatments, and integrated health management solutions”.
“Medical specialists in men’s health will be providing medical advice as well as pharmacists. It will be a national offering,” said the LTR Pharma spokesperson.
As yet there are no details available on where the medical specialists and pharmacists will be based, whether they will be Australian-trained and registered, how much consultations and treatments will cost, and how or if patients will be followed-up.
According to LTR Pharma’s announcement the global telehealth market is valued at over USD $140 billion in 2023, with a projected growth rate of 22% annually through to 2032.
“This joint venture represents a significant milestone in LTR Pharma’s strategic commercialisation plan,” said company chairman Lee Rodne.
“By partnering with an established leader in men’s health services, we are well-positioned to meet the growing demand for accessible healthcare solutions.
“The online platform will provide a discrete and convenient channel for men to access professional healthcare services and prescribed treatments.”
Related
Melissa Hadley Barrett, founder of the RSHC said:
“This partnership aligns perfectly with our mission to provide comprehensive, evidence-based care that enhances men’s well-being.
“The online platform will expand access to our professional services while maintaining the high standards of care that define our face-to-face clinic.
“We look forward to working with LTR Pharma to deliver innovative healthcare solutions that make a meaningful difference in men’s lives,” she said.
